Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens

Jill R. Blankenship, Nina Singh, Barbara D. Alexander, Joseph Heitman

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

The immunosuppressants tacrolimus (FK506) and cyclosporine A inhibit calcineurin and have potent antifungal activity. In this study, 24% of Cryptococcus neoformans isolates from solid-organ transplant patients exhibited altered sensitivity to these drugs, which may have an impact on the infectious course but does not appear to be the consequence of immunosuppressive therapy.

Original languageEnglish (US)
Pages (from-to)464-467
Number of pages4
JournalJournal of clinical microbiology
Volume43
Issue number1
DOIs
StatePublished - Jan 2005

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens'. Together they form a unique fingerprint.

  • Cite this